Michael J. LaBarre, SVP, CHIEF TECHNICAL OFFICER at HALOZYME THERAPEUTICS, INC. (HALO), sold 30,000 shares at $41.64 ($1.3M) on 2024-03-12, disclosed to the SEC on 2024-03-13.
Scheduled sale ($1.3M) by SVP, CHIEF TECHNICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.64 | 10,000 | $416K | 33.0% |
| 2 | $42.27 | 10,000 | $423K | 33.5% |
| 3 | $42.27 | 10,000 | $423K | 33.5% |
| Total | $42.06 avg | 30,000 | $1.3M | 100% |
| Filing → |
| HALO | SELL | 2024-09-18 | $1.9M | — | Filing → |
| HALO | SELL | 2024-08-21 | $1.2M | — | Filing → |
| HALO | SELL | 2024-07-24 | $1.6M | — | Filing → |